Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M L Shiffman

Showing results (41-50 of 99) with videos related to

Pageof 10
Sort By:
The American Journal of Gastroenterology|August 1, 1991
Gallstone formation after rapid weight loss: a prospective study in patients undergoing gastric bypass surgery for treatment of morbid obesityM L Shiffman, H J Sugerman, J M Kellum, et al.
Alimentary Pharmacology & Therapeutics|February 19, 2010
Clinical trial: the efficacy and safety of oral PF-03491390, a pancaspase inhibitor - a randomized placebo-controlled study in patients with chronic hepatitis CM L Shiffman, P Pockros, J G McHutchison, et al.
Hepatology (Baltimore, Md.)|January 1, 1996
The hematologic consequences of transjugular intrahepatic portosystemic shuntsA J Sanyal, A M Freedman, P P Purdum, et al.
The Journal of Infectious Diseases|July 27, 2001
A randomized, controlled trial to determine whether continued ribavirin monotherapy in hepatitis C virus-infected patients who responded to interferon-ribavirin combination therapy will enhance sustained virologic responseM L Shiffman, C M Hofmann, R K Sterling, et al.
Hepatology (Baltimore, Md.)|July 1, 1996
Improved sustained response following treatment of chronic hepatitis C by gradual reduction in the interferon doseM L Shiffman, C M Hofmann, V A Luketic, et al.
Gastroenterology|October 1, 1993
Gallbladder mucin, arachidonic acid, and bile lipids in patients who develop gallstones during weight reductionM L Shiffman, R D Shamburek, C C Schwartz, et al.
Hepatology (Baltimore, Md.)|July 1, 1994
Portosystemic encephalopathy after transjugular intrahepatic portosystemic shunt: results of a prospective controlled studyA J Sanyal, A M Freedman, M L Shiffman, et al.
Annals of Internal Medicine|February 11, 1991
Primary hepatocellular carcinoma after orthotopic liver transplantation for chronic hepatitis B infectionV A Luketic, M L Shiffman, J B McCall, et al.
Alimentary Pharmacology & Therapeutics|July 20, 2007
Portal-systemic shunting in patients with fibrosis or cirrhosis due to chronic hepatitis C: the minimal model for measuring cholate clearances and shuntG T Everson, M A Martucci, M L Shiffman, et al.
Transplantation Proceedings|February 1, 1993
Hepatic lidocaine metabolism is useful in the selection of patients in need of liver transplantationV A Luketic, M L Shiffman, R A Fisher, et al.
Pageof 10

Showing results (41-50 of 99) with videos related to

Sort By:
Pageof 10
The American Journal of Gastroenterology|August 1, 1991
Gallstone formation after rapid weight loss: a prospective study in patients undergoing gastric bypass surgery for treatment of morbid obesityM L Shiffman, H J Sugerman, J M Kellum, et al.
Alimentary Pharmacology & Therapeutics|February 19, 2010
Clinical trial: the efficacy and safety of oral PF-03491390, a pancaspase inhibitor - a randomized placebo-controlled study in patients with chronic hepatitis CM L Shiffman, P Pockros, J G McHutchison, et al.
Hepatology (Baltimore, Md.)|January 1, 1996
The hematologic consequences of transjugular intrahepatic portosystemic shuntsA J Sanyal, A M Freedman, P P Purdum, et al.
The Journal of Infectious Diseases|July 27, 2001
A randomized, controlled trial to determine whether continued ribavirin monotherapy in hepatitis C virus-infected patients who responded to interferon-ribavirin combination therapy will enhance sustained virologic responseM L Shiffman, C M Hofmann, R K Sterling, et al.
Hepatology (Baltimore, Md.)|July 1, 1996
Improved sustained response following treatment of chronic hepatitis C by gradual reduction in the interferon doseM L Shiffman, C M Hofmann, V A Luketic, et al.
Gastroenterology|October 1, 1993
Gallbladder mucin, arachidonic acid, and bile lipids in patients who develop gallstones during weight reductionM L Shiffman, R D Shamburek, C C Schwartz, et al.
Hepatology (Baltimore, Md.)|July 1, 1994
Portosystemic encephalopathy after transjugular intrahepatic portosystemic shunt: results of a prospective controlled studyA J Sanyal, A M Freedman, M L Shiffman, et al.
Annals of Internal Medicine|February 11, 1991
Primary hepatocellular carcinoma after orthotopic liver transplantation for chronic hepatitis B infectionV A Luketic, M L Shiffman, J B McCall, et al.
Alimentary Pharmacology & Therapeutics|July 20, 2007
Portal-systemic shunting in patients with fibrosis or cirrhosis due to chronic hepatitis C: the minimal model for measuring cholate clearances and shuntG T Everson, M A Martucci, M L Shiffman, et al.
Transplantation Proceedings|February 1, 1993
Hepatic lidocaine metabolism is useful in the selection of patients in need of liver transplantationV A Luketic, M L Shiffman, R A Fisher, et al.
Pageof 10